GB1412591A - Antiviral ds rna and compositions thereof - Google Patents
Antiviral ds rna and compositions thereofInfo
- Publication number
- GB1412591A GB1412591A GB5542571A GB5542571A GB1412591A GB 1412591 A GB1412591 A GB 1412591A GB 5542571 A GB5542571 A GB 5542571A GB 5542571 A GB5542571 A GB 5542571A GB 1412591 A GB1412591 A GB 1412591A
- Authority
- GB
- United Kingdom
- Prior art keywords
- ribonucleic acid
- component
- polyanion
- double
- antiviral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000000840 anti-viral effect Effects 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 229920002477 rna polymer Polymers 0.000 abstract 5
- 125000000539 amino acid group Chemical group 0.000 abstract 4
- 229920000447 polyanionic polymer Polymers 0.000 abstract 4
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 241000892910 Aspergillus foetidus Species 0.000 abstract 1
- 241000228245 Aspergillus niger Species 0.000 abstract 1
- 241000228145 Penicillium brevicompactum Species 0.000 abstract 1
- 241000228150 Penicillium chrysogenum Species 0.000 abstract 1
- 108010039918 Polylysine Proteins 0.000 abstract 1
- 108010007568 Protamines Proteins 0.000 abstract 1
- 102000007327 Protamines Human genes 0.000 abstract 1
- 125000000129 anionic group Chemical group 0.000 abstract 1
- 125000002091 cationic group Chemical group 0.000 abstract 1
- 229920000724 poly(L-arginine) polymer Polymers 0.000 abstract 1
- 108010011110 polyarginine Proteins 0.000 abstract 1
- 229920000656 polylysine Polymers 0.000 abstract 1
- 108010055896 polyornithine Proteins 0.000 abstract 1
- 229920002714 polyornithine Polymers 0.000 abstract 1
- 229940048914 protamine Drugs 0.000 abstract 1
- 230000003362 replicative effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1412591 Antiviral RNA complexes BEECHAM GROUP Ltd 21 Nov 1972 [30 Nov 1971] 55425/71 Heading C3H [Also in Division A5] An antiviral ds RNA complex which is a principally ionic complex, the cationic component being a non-cross-linked polypeptide in which at least 50% of the component amino acids are basic, the free amino acid group or groups of which are protonated, and the anionic component being either (a) double-stranded ribonucleic acid polyanion, said double-stranded ribonucleic acid being of natural origin or (b) a polyanion of a double-stranded derivative of a double-stranded ribonucleic acid of natural origin. The catioric component is preferably a non-cross-linked polypeptide in which at least 70% of the component amino acids are basic, the free amino acid group or groups of which are protonated and may be, e.g. polylysine, polyornithine, a protamine, or polyarginine. The polyanion is preferably the polyanion of the ribonucleic acid found in infected strains of Penicillium chrysogenum, P. stoloniferum, Aspergillus niger or A. foetidus, or of the ribonucleic acid of the replicative form of a phage, e.g. the MU-9 mutant of MS2 coliphage.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5542571A GB1412591A (en) | 1971-11-30 | 1971-11-30 | Antiviral ds rna and compositions thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5542571A GB1412591A (en) | 1971-11-30 | 1971-11-30 | Antiviral ds rna and compositions thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1412591A true GB1412591A (en) | 1975-11-05 |
Family
ID=10473869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB5542571A Expired GB1412591A (en) | 1971-11-30 | 1971-11-30 | Antiviral ds rna and compositions thereof |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB1412591A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0009498A4 (en) * | 1978-01-16 | 1980-10-16 | Univ Boston | Effecting cellular uptake of molecules. |
| US4530901A (en) * | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
| EP0213921A3 (en) * | 1985-08-26 | 1988-01-07 | Hem Research, Inc. | Modulation of virus-related events by double-stranded rnas |
| US4820696A (en) * | 1985-08-26 | 1989-04-11 | Hem Research, Inc. | Modulation of aids virus-related events by double-stranded RNAS |
| WO1990000894A1 (en) * | 1988-07-19 | 1990-02-08 | Laboratoires Serobiologiques | Cyto-photo-protector agent based on nucleic acids and/or their derivatives |
| DE3990820T1 (en) * | 1988-07-19 | 1990-07-19 | Serobiologiques Lab Sa | LIGHT PROTECTION AGENT FOR SKIN CELLS BASED ON NUCLEIC ACIDS AND / OR THEIR DERIVATIVES |
| US6835557B1 (en) | 1980-01-08 | 2004-12-28 | Biogen, Inc. | DNA sequences, recombinant DNA molecules and processes for producing human interferon-like polypeptides |
| EP1541690A3 (en) * | 1999-09-09 | 2005-07-27 | CureVac GmbH | Transfer of mRNA using polycationic compounds |
-
1971
- 1971-11-30 GB GB5542571A patent/GB1412591A/en not_active Expired
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0009498A4 (en) * | 1978-01-16 | 1980-10-16 | Univ Boston | Effecting cellular uptake of molecules. |
| US4530901A (en) * | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
| US6835557B1 (en) | 1980-01-08 | 2004-12-28 | Biogen, Inc. | DNA sequences, recombinant DNA molecules and processes for producing human interferon-like polypeptides |
| US4820696A (en) * | 1985-08-26 | 1989-04-11 | Hem Research, Inc. | Modulation of aids virus-related events by double-stranded RNAS |
| EP0213921A3 (en) * | 1985-08-26 | 1988-01-07 | Hem Research, Inc. | Modulation of virus-related events by double-stranded rnas |
| WO1990000894A1 (en) * | 1988-07-19 | 1990-02-08 | Laboratoires Serobiologiques | Cyto-photo-protector agent based on nucleic acids and/or their derivatives |
| DE3990820T1 (en) * | 1988-07-19 | 1990-07-19 | Serobiologiques Lab Sa | LIGHT PROTECTION AGENT FOR SKIN CELLS BASED ON NUCLEIC ACIDS AND / OR THEIR DERIVATIVES |
| GB2233557A (en) * | 1988-07-19 | 1991-01-16 | Serobiologiques Lab Sa | Cyto-photo-protector agent based on nucleic acids and/or their derivatives |
| GB2233557B (en) * | 1988-07-19 | 1993-03-31 | Serobiologiques Lab Sa | An agent for cytoprotection based on nucleic acids and/or derivatives thereof |
| DE3990820C2 (en) * | 1988-07-19 | 2001-02-15 | Lab Serobiologiques Pulnoy | Light stabilizers for skin cells based on ribonucleic acids and derivatives thereof, as well as derivatives of ribonucleotides |
| EP1541690A3 (en) * | 1999-09-09 | 2005-07-27 | CureVac GmbH | Transfer of mRNA using polycationic compounds |
| EP1619254A1 (en) * | 1999-09-09 | 2006-01-25 | CureVac GmbH | Transfer of mRNA using polycationic compounds |
| EP1818409A1 (en) * | 1999-09-09 | 2007-08-15 | CureVac GmbH | Transfer of mRNAusing polycationic compounds |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1451415A (en) | Stabilization of iron-containing acidic hydrogen peroside solutions | |
| CA1032946A (en) | Esters of 2,2,6,6-tetramethylpiperidinols and hydroxybenzylmalonic acids | |
| CA921035A (en) | Process for the preparation of unsymmetrical esters of 1,4-dihydropyridine 3,5-dicarboxylic acid | |
| EP0377526A3 (en) | Use of copper complexes of alpha-amino acids that contain terminal amino groups as nutritional supplements | |
| GB1412591A (en) | Antiviral ds rna and compositions thereof | |
| ES406876A1 (en) | Copolymers of 1-alkenes and acrylic acid derivatives | |
| SE8901041D0 (en) | ANTITROMOBOTIC PHARMACEUTICAL PREPARATIONS AND PROCEDURES FOR THEIR PREPARATION | |
| CA989864A (en) | Metal derivatives of 3,5-di-t-butyl-hydroxyphenylpropionic acid and compositions containing these derivatives | |
| GB1410013A (en) | Biologically active material | |
| GB1520915A (en) | Scale control agents | |
| FR2329707A1 (en) | AQUEOUS FILM-GENERATING DISPERSIONS OF SYNTHETIC RESINS USED AS BINDERS IN COATING PRODUCTS | |
| GB1499480A (en) | Process for the manufacture of pure substituted 2,5-diarylaminoterephthalates and the corresponding free acids | |
| CA976026A (en) | Bland amino acid compositions | |
| IE33230L (en) | Anti-haemorrhoidal preparations | |
| GB1434595A (en) | Pharmaceutical compositions | |
| CA984849A (en) | Metal complexes of n,n'-dialkylesters of ethylenedinitrilotetraacetic acid and compositions stabilized thereby | |
| ES375079A1 (en) | 3-alkoxy-or 3-aryloxy-2-(diaryl-hydroxy)-methyl-propylamines | |
| GB1398098A (en) | Chlorosulphonylxanthone carboxylic acids | |
| CA1026767A (en) | N,n'-dichloroamides of terephthalic and isophthalic acid | |
| GB1261363A (en) | Acid carboxypeptidase and the preparation thereof | |
| BE753579A (en) | NEW ESTERS-AMIDES OF THIOPHOSPHORIC ACID, THEIR PREPARATION AND THEIR APPLICATION AS PRODUCTS | |
| GB1417817A (en) | Substituted acetic acid cyclohexyl esters the preparation thereof and pharmaceutical compositions containing them | |
| IL46524A (en) | Antiviral ribonucleic acids complexes, their preparation and pharmaceutical compositions containing them | |
| IE36719B1 (en) | Preparation of n-(1-ethyl-alpha-pyrrolidylmethyl)-2-methoxy-5-sulfonamidobenzamide | |
| JPS51148090A (en) | Process for stabilizing an aqueous lysozyme solution |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |